Page last updated: 2024-09-05

sb 203580 and Chloasma

sb 203580 has been researched along with Chloasma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, JY; Han, BS; Kang, M; Lee, J; Lee, S; Lee, SE; Nho, YH; Oh, SW; Park, SH; Yoo, JA1

Other Studies

1 other study(ies) available for sb 203580 and Chloasma

ArticleYear
Anti-melanogenic effects of resorcinol are mediated by suppression of cAMP signaling and activation of p38 MAPK signaling.
    Bioscience, biotechnology, and biochemistry, 2018, Volume: 82, Issue:7

    Topics: Animals; Cell Line, Tumor; Cells, Cultured; Cyclic AMP; Drug Interactions; Enzyme Activation; Gene Expression; Humans; Imidazoles; Indoles; Intramolecular Oxidoreductases; MAP Kinase Signaling System; Melanins; Melanocytes; Melanosis; Membrane Glycoproteins; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Oxidoreductases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Real-Time Polymerase Chain Reaction; Resorcinols

2018